NDC 52533-170
Oxytocin
Oxytocin
Oxytocin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Cantrell Drug Company. The primary component is Oxytocin.
| Product ID | 52533-170_494203c0-7b4f-474f-9582-048d148d65f4 |
| NDC | 52533-170 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oxytocin |
| Generic Name | Oxytocin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2011-07-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Cantrell Drug Company |
| Substance Name | OXYTOCIN |
| Active Ingredient Strength | 30 [USP'U]/500mL |
| Pharm Classes | Increased Uterine Smooth Muscle Contraction or Tone [PE],Oxytocic [EPC],Oxytocin [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 52533-170-30
500 mL in 1 BAG (52533-170-30)
| Marketing Start Date | 2011-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 52533-170-30 [52533017030]
Oxytocin INJECTION, SOLUTION
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-12-11 |
| Inactivation Date | 2020-01-31 |
NDC 52533-170-32 [52533017032]
Oxytocin INJECTION, SOLUTION
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-07-01 |
| Marketing End Date | 2014-12-11 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| OXYTOCIN | 30 [USP'U]/500mL |
OpenFDA Data
| SPL SET ID: | 89156ba1-931f-4f3f-ab8a-b1b63e9e4c63 |
| Manufacturer | |
| UNII |
Pharmacological Class
- Increased Uterine Smooth Muscle Contraction or Tone [PE]
- Oxytocic [EPC]
- Oxytocin [CS]
NDC Crossover Matching brand name "Oxytocin" or generic name "Oxytocin"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9742 | Oxytocin | Oxytocin |
| 0143-9743 | Oxytocin | Oxytocin |
| 0641-6114 | Oxytocin | Oxytocin |
| 0641-6115 | Oxytocin | Oxytocin |
| 52533-048 | Oxytocin | Oxytocin |
| 52533-051 | Oxytocin | Oxytocin |
| 52533-054 | Oxytocin | Oxytocin |
| 52533-055 | Oxytocin | Oxytocin |
| 52533-056 | Oxytocin | Oxytocin |
| 52533-105 | Oxytocin | Oxytocin |
| 52533-170 | Oxytocin | Oxytocin |
| 52533-233 | Oxytocin | Oxytocin |
| 52533-234 | Oxytocin | Oxytocin |
| 55154-9356 | Oxytocin | OXYTOCIN |
| 55154-9577 | Oxytocin | OXYTOCIN |
| 55154-9584 | Oxytocin | OXYTOCIN |
| 63323-012 | Oxytocin | OXYTOCIN |
| 42023-116 | Pitocin | oxytocin |
| 42023-130 | Pitocin | oxytocin |
Trademark Results [Oxytocin]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OXYTOCIN 78368996 not registered Dead/Abandoned |
Hirsch, Eric Michael 2004-02-17 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.